It was formerly demonstrated that PL retard and Choi accelerates the formation of tumours induced by M e C 2 . This retardation respectively acceleration, however, never surpassed a period of somewhat more than four weeks. The question, then, arose why PL are only capable to retard temporarily and not to pre vent, i. e. retard permanently, the formation of tu mours. It was presumed that the administration of an excess of PL could favourably influence the time of re tardation, namely by impeding the liberation of MeC from its molecular associations with PL through the interaction of Choi occurring everywhere in the or ganism :
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A series of attempts have, therefore, been under taken in order to increase respectively decrease the PL/Chol-ratio in the organism by the administration of excessive quantities of PL respectively Choi. The obtained results were all negative for neither the re tardation by excess of PL, nor the acceleration by ex cess of Choi of the formation of tumours could be pro longed for more than four weeks.
Method and Results
Eleven groups of twenty Swiss mice each were form ed.
The controls (Group I) were injected subcutaneously in one single dose with 0.5 mg MeC in 0.2 ml trioctanoin (Eastman-Kodak). Group II received 0.5 mg MeC plus 50 mg of "Asolectin" ** in 0.2 ml trioctanoin. This same injection was applied in the mice of Groups III, IV, V and VI to which, however, additional quan tities of PL were given, namely: to Group III, already 35 days before the application of MeC, a 1% Asolectinemulsion as the drinking water which corresponds with a daily dose of about 1.5 g PL/kg bodyweight; to Group IV: starting 15 days before the MeC-injection, three times weekly 0.1 ml of a 10% emulsion of Aso lectin in saline 0.9% subcutaneously, corresponding with a dose of 1 g PL/week/kg bodyweight; to Group V: initiating 15 days before the MeC-dosage, equally three times weekly 0.1 ml of the same Asolectin-emulsion, intraperitoneally; and to Group V I: 0.1 ml of a L. S. P i n t o , Arch. Geschwulstforsch. 31, 133 [1968] , 2% phosphatidylcholine-emulsion three times weekly in the tail-vein, corresponding with 200 mg PL/week/kg bodyweight. The animals of Group V II were injected subcutane ously with a single dose of 0.5 mg MeC plus 20 mg Choi dissolved in 0.2 ml trioctanion, whereas those of Group V III received, in addition to that injection and starting already 35 days before the MeC-administration, 4 g Choi dissolved in 80 ml babassu-fat *** per kg of ration which corresponds with a dose of about 1 g Chol/day/kg bodyweight. The additional quantities of Choi for Groups IX and X were administered sub cutaneous respectively intraperitoneally three times weekly in doses of 0.1 ml of a 5% Chol-solution in babassu-fat slightly warmed at 40 °C to prevent Cholcrystallisation. This dose corresponds with about 500 mg Chol/week/kg bodyweight. Group X I, finally, re ceived the additional dose of Choi intravenously in the form of an O/W-emulsion, containing 0.8% Choi and stabilized with sodium stearate. This emulsion was in troduced three times weekly in a dose of 0.1 ml which corresponds with 75 -100 mg Chol/week/kg body weight.
The appearance of tumours was controlled twice weekly from the 3rd to the 7th week and, thereafter, three times a week. The results are summarized in the Table 1 , in which the three figures a/b/c represent: (a) the total number of living mice, (b) the number of living tumour-bearing mice, and (c) the number of mice died from cancer.
Discussion
It is seen from the figures in the Table 1 that in the twelfth week after MeC-injection, already half of the control mice had acquired cancer, whereas only 15% of Group II, about 36% of Group III, 22% of Group IV, and 28% of Group V beared tumours. In the Chol-groups, on the contrary, these percentages amount to not less than 89 for Group VII, 90 for Group V III, 95 for Group IX, and 94 for Group X.
Thus, with the exception of the mice which have received either PL or Choi intravenously, it can be positively stated that PL retard the appearance of tu mours, whereas Choi showed a pronounced accelerat ing activity. The same is true for the rate of mortality. Thirty weeks after the MeC-injection, namely, one animal of the control-group, three of Group II, one of Group I I I and two of Group IV escaped tumour-formation and survived, whereas already 16 weeks after MeC-administration, all mice of the Chol-groups have died from cancer, excepted those of Group V II which, however, were all tumour-bearing and, hence, con demned to death. The mice of Groups IV, V, IX and X ** This granulated soybean phosphatide was gently put at our disposal by Mr. J. E i c h b e r g , President of American Leci thin Cy., Atlanta, USA. *** Babassu-fat was gently put at our disposal by Dr. must have suffered from the received subcutaneous and intraperitoneal injections for a large excess of un absorbed PL-emulsion, respectively oil-solutions of Choi, was constantly found either subcutaneously or in the abdominal cavity.
A high mortality was observed in the intravenously injected mice, probably as a consequence of the im perfect condition of the introduced emulsions due to lack of an adequate stabilizer which, in the meantime, has been found in Pluronic F-68, a non-ionic, watersoluble polyoxyethyleneoxypropylene polymer produced by Wyandotte Chemical Corp., Wyandotte, U S A 3. ft seems worth while to repeat the introduction of either PL or Choi directly in the bloodstream for the excess of these lipids when administered by other ways has not shown the slightest effect, probably due to metabolic modifications of their molecular structures. However it may be, it must be concluded from the 3 P. E. S c h u r r , Cancer Res. 29, 258 [1969] . 4 R. F. A . A l t m a n , Arch. Geschwulstforsch. 19, 1, 97 [1962] .
above that the activity of PL and Choi is only per ceptible when these compounds find themselves in di rect molecular contact with the carcinogen. This con firms the assumed existence of molecular associations of PL and MeC from which MeC can be released by Choi, due to the higher affinity of the latter to PL (see the equation given in the Introduction). As was already explained before1, PL-MeC associations are too large in size for occupying open spaces in the cellmembranes (cf. A l t m a n 5) .
Experiments are now in progress to verify the acti vity of a large excess of PL and Choi introduced together with the carcinogenic hydrocarbon. At the same time, the influence of an excess of these lipids administered intravenously in the form of perfect emulsions is stu died. 
